Bluefin Biomedicine Inc.
- Address
- 32 Tozer Road
Sponsor Overview
Specializations
Atopic Dermatitis
Bluefin Biomedicine Inc. is involved in clinical research for atopic dermatitis, with attention to inflammatory skin disease in adult male and female participants. The sponsor’s work in this area centers on evaluating treatment effects on skin signs and symptom burden.
- Eczema Area and Severity Index
- Inflammatory skin inflammation
- Adult dermatology
The sponsor’s dermatology portfolio includes studies designed to address disease activity in eczema and related immune-mediated skin conditions.
Hidradenitis Suppurativa
The company also supports research in hidradenitis suppurativa, focusing on a chronic, recurrent inflammatory skin disorder marked by abscesses and inflammatory nodules. This area reflects interest in difficult-to-treat dermatologic disease with significant local inflammation.
- Abscesses
- Inflammatory nodules
- Moderate to severe disease
Bluefin Biomedicine Inc. is active in clinical evaluation of therapies for HS across multiple research sites and countries.
Inflammatory Dermatology
Across its funded trials, the sponsor’s therapeutic interests are concentrated in immune-mediated and chronic inflammatory skin diseases. The research landscape includes conditions with persistent redness, lesion formation, and ongoing tissue inflammation.
- Chronic skin inflammation
- Lesion burden
- Dermatologic symptom control
These studies place emphasis on clinically meaningful skin outcomes relevant to patients living with long-term dermatologic disease.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients with Moderate to Severe Hidradenitis Suppurativa |  Bulgaria Czechia Germany Poland Spain | Recruiting |
| Efficacy and Safety Evaluation of BFB759 in Adult Patients with Atopic Dermatitis: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study | Bulgaria Czechia Germany Poland Spain | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 52 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases2 trials322 other sponsors
- 2.Skin and Connective Tissue Diseases2 trials247 other sponsors
Partnered Research Centres
52 centres- Address
- Ploshtad Svoboda 1, 2600 Dupnitsa
- Address
- 28. Rijna 3348/65, Moravska Ostrava, 702 00 Moravska Ostrava A Privoz
- Address
- Ul. Na Zaspe 3, 80-546 Gdansk
- Address
- Ul. Marii Konopnickiej 4, 82-200 Malbork
- Address
- Ul. Krolowej Jadwigi 16, 85-231 Bydgoszcz
- Address
- Ul. Gabrieli Zapolskiej 3, 41-218 Sosnowiec
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Bluefin Biomedicine Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.